All AbMole products are for research use only, cannot be used for human consumption.
Dehydrolithocholic acid is a bile acid metabolite, which inhibits the diferentiation of TH17 cells by directly binding to the key transcription factor RORγt (Kd=1.13 μM).
| Molecular Weight | 374.56 |
| Formula | C24H38O3 |
| CAS Number | 1553-56-6 |
| Solubility (25°C) | DMSO 60 mg/mL |
| Storage | -20°C, sealed |
[2] Karl Bodin, et al. Biochim Biophys Acta. Novel pathways of bile acid metabolism involving CYP3A4
[4] T Tateyama, et al. Lipids. Metabolism of chenodeoxycholic acid in hamsters
| Related ROR Products |
|---|
| ASN06917370
ASN06917370 is a former orphan receptor GPR17 ligand for the study of neurodegenerative diseases. |
| JTE-151
JTE-151 is a RORγ inhibitor that suppresses overactive immune responses by inhibiting RORγ associated with Th17 cell activation.JTE-151 can be used in studies related to autoimmune diseases. |
| SAR-441169
SAR-441169 is a RORγt inverse agonist that can be used in studies related to psoriasis. |
| GRC-39815
GRC-39815 is a RORγt inverse agonist that can be used in studies related to chronic obstructive pulmonary disease. |
| RORγ antagonist 1
RORγ antagonist 1, a potent betulinic acid derivative, is an antagonist of RORγ (KD=0.18 μM). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
